FDA Approves Fenfluramine for Lennox-Gastaut Syndrome Phase 3 Clinical Data Finds It Is Effective

The US Food and Drug Administration approved fenfluramine for Lennox-Gastaut syndrome based on data that found that the frequency of certain seizure subtypes, notably generalized tonic-clonic seizures, dropped in a dose-dependent way compared with a group taking placebo.